Results 221 to 230 of about 40,797 (259)
Some of the next articles are maybe not open access.
Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial.
Pediatrics, 2022BACKGROUND Evidence regarding the safety and efficacy of anticoagulant thromboprophylaxis among pediatric patients hospitalized for COVID-19 is limited.
A. Sochet +15 more
semanticscholar +1 more source
Current Opinion in Critical Care, 2008
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire +2 more sources
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire +2 more sources
Thromboprophylaxis in Microsurgery
Acta Chirurgica Belgica, 2006Microsurgical free tissue transfer has become a gold standard in a wide range of clinical situations. Thrombosis at the anastomotic site is not only the most common cause of failure of microsurgical operations, but it is also one of the factors resulting in microcirculatory intravascular thrombosis in free flaps.
Lecoq, Jean-Pierre +4 more
openaire +2 more sources
2023
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire +1 more source
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire +1 more source
Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial
European Journal of Clinical Investigation, 2021It is uncertain whether higher doses of anticoagulants than recommended for thromboprophylaxis are necessary in COVID‐19 patients hospitalized in general ...
N. Morici +14 more
semanticscholar +1 more source
Thromboprophylaxis in Pregnancy
Obstetrics and Gynecology Clinics of North America, 2018Venous thromboembolism is a leading cause of maternal morbidity and mortality worldwide. Identifying women who are at greatest risk for venous thromboembolism, and managing their pregnancies with appropriate thromboprophylaxis is essential to decreasing this life-threatening condition. Those at greatest risk are patients with thrombophilias, a personal
Diana, Kolettis, Sabrina, Craigo
openaire +2 more sources
Thromboprophylaxis in multiple myeloma
Leukemia & Lymphoma, 2022Venous thromboembolism (VTE) in multiple myeloma (MM) can be secondary to patient-, disease-, and/or treatment-related factors. The development of VTE may result in significant morbidity with the highest risk during the first year after diagnosis. This clinical review provides an evidence-based summary to guide practicing oncologists in the use of ...
Nishanth, Thalambedu, Samer, Al Hadidi
openaire +2 more sources
Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol
Obstetrics and Gynecology, 2021Risk-stratified heparin-based obstetric thromboprophylaxis was associated with increased wound and bleeding complications without decreased postpartum venous thromboembolisms.
Michelle Lu +18 more
semanticscholar +1 more source
Current Vascular Pharmacology, 2021
BACKGROUND Venous thromboembolism (VTE) is common among patients with severe coronavirus disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefits; however, the optimal thromboprophylaxis ...
K. Kyriakoulis +9 more
semanticscholar +1 more source
BACKGROUND Venous thromboembolism (VTE) is common among patients with severe coronavirus disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefits; however, the optimal thromboprophylaxis ...
K. Kyriakoulis +9 more
semanticscholar +1 more source
British journal of hospital medicine, 1993
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source